Follow the people · Insider
Stephen P. Carey
Stephen P. Carey files insider transactions with the SEC as a svp & cfo of Ani Pharmaceuticals (ANIP). We hold 6 disclosed purchases and sales filed since 10 May 2016, 4 of them in the last 90 days.
- Files forANIP
- Disclosed buys and sells6 in all, 4 in the last 90 days
- Last disclosure1 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 6 May 2016 — 31 August 2026SVP & CFO · Ani Pharmaceuticals (ANIP)80 Form 4 lines · source: SEC Form 4
Everything they disclosed
80 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 2,850 shares of Ani PharmaceuticalsSEC Form 41 September 2026Common Stock · traded 31 August 2026 · filed 1 September 2026
- ▼ sold on the open market 2,850 shares of Ani PharmaceuticalsSEC Form 430 July 2026Common Stock · traded 29 July 2026 · filed 30 July 2026
- exercised options over 3,313 shares of Ani PharmaceuticalsSEC Form 46 July 2026Common Stock · traded 2 July 2026 · filed 6 July 2026
- ▼ sold on the open market 3,313 shares of Ani PharmaceuticalsSEC Form 46 July 2026Common Stock · traded 2 July 2026 · filed 6 July 2026
- exercised options over 3,313 shares of Ani Pharmaceuticals (a derivative holding)SEC Form 46 July 2026Stock Option (right to buy) · traded 2 July 2026 · filed 6 July 2026
- ▼ sold on the open market 2,850 shares of Ani PharmaceuticalsSEC Form 430 June 2026Common Stock · traded 29 June 2026 · filed 30 June 2026
- exercised options over 3,312 shares of Ani PharmaceuticalsSEC Form 49 June 2026Common Stock · traded 5 June 2026 · filed 9 June 2026
- ▼ sold on the open market 3,312 shares of Ani PharmaceuticalsSEC Form 49 June 2026Common Stock · traded 5 June 2026 · filed 9 June 2026
- exercised options over 3,312 shares of Ani Pharmaceuticals (a derivative holding)SEC Form 49 June 2026Stock Option (right to buy) · traded 5 June 2026 · filed 9 June 2026
- had shares withheld for tax on 5,150 shares of Ani PharmaceuticalsSEC Form 410 March 2026Common Stock · traded 7 March 2026 · filed 10 March 2026
- had shares withheld for tax on 5,150 shares of Ani PharmaceuticalsSEC Form 410 March 2026Common Stock · traded 7 March 2026 · filed 10 March 2026
- exercised options over 3,312 shares of Ani PharmaceuticalsSEC Form 45 March 2026Common Stock · traded 5 March 2026 · filed 5 March 2026
- ▼ sold on the open market 3,312 shares of Ani PharmaceuticalsSEC Form 45 March 2026Common Stock · traded 5 March 2026 · filed 5 March 2026
- ▼ sold on the open market 4,000 shares of Ani PharmaceuticalsSEC Form 45 March 2026Common Stock · traded 5 March 2026 · filed 5 March 2026
- exercised options over 3,312 shares of Ani Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Stock Option (right to buy) · traded 5 March 2026 · filed 5 March 2026
- exercised options over 3,312 shares of Ani Pharmaceuticals (a derivative holding)SEC Form 45 March 2026Stock Option (right to buy) · traded 5 March 2026 · filed 5 March 2026
- exercised options over 3,312 shares of Ani PharmaceuticalsSEC Form 45 March 2026Common Stock · traded 5 March 2026 · filed 5 March 2026
- ▼ sold on the open market 3,312 shares of Ani PharmaceuticalsSEC Form 45 March 2026Common Stock · traded 5 March 2026 · filed 5 March 2026
- ▼ sold on the open market 4,000 shares of Ani PharmaceuticalsSEC Form 45 March 2026Common Stock · traded 5 March 2026 · filed 5 March 2026
- was granted 22,233 shares of Ani PharmaceuticalsSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 2,773 shares of Ani PharmaceuticalsSEC Form 42 March 2026Common Stock · traded 28 February 2026 · filed 2 March 2026
- was granted 22,233 shares of Ani PharmaceuticalsSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 2,773 shares of Ani PharmaceuticalsSEC Form 42 March 2026Common Stock · traded 28 February 2026 · filed 2 March 2026
- had shares withheld for tax on 2,829 shares of Ani PharmaceuticalsSEC Form 417 February 2026Common Stock · traded 12 February 2026 · filed 17 February 2026
- had shares withheld for tax on 2,448 shares of Ani PharmaceuticalsSEC Form 417 February 2026Common Stock · traded 14 February 2026 · filed 17 February 2026
- had shares withheld for tax on 2,829 shares of Ani PharmaceuticalsSEC Form 417 February 2026Common Stock · traded 12 February 2026 · filed 17 February 2026
- had shares withheld for tax on 2,448 shares of Ani PharmaceuticalsSEC Form 417 February 2026Common Stock · traded 14 February 2026 · filed 17 February 2026
- had shares withheld for tax on 5,503 shares of Ani PharmaceuticalsSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- had shares withheld for tax on 5,503 shares of Ani PharmaceuticalsSEC Form 413 February 2026Common Stock · traded 11 February 2026 · filed 13 February 2026
- exercised options over 50,000 shares of Ani Pharmaceuticals (a derivative holding)SEC Form 414 August 2025Stock Option (right to buy) · traded 12 August 2025 · filed 14 August 2025
- exercised options over 50,000 shares of Ani PharmaceuticalsSEC Form 414 August 2025Common Stock · traded 12 August 2025 · filed 14 August 2025
- ▼ sold on the open market 50,000 shares of Ani PharmaceuticalsSEC Form 414 August 2025Common Stock · traded 12 August 2025 · filed 14 August 2025
- had shares withheld for tax on 6,210 shares of Ani PharmaceuticalsSEC Form 425 March 2025Common Stock · traded 23 March 2025 · filed 25 March 2025
- had shares withheld for tax on 5,150 shares of Ani PharmaceuticalsSEC Form 414 March 2025Common Stock · traded 7 March 2025 · filed 14 March 2025
- had shares withheld for tax on 1,861 shares of Ani PharmaceuticalsSEC Form 44 March 2025Common Stock · traded 28 February 2025 · filed 4 March 2025
- was granted 24,808 shares of Ani PharmaceuticalsSEC Form 418 February 2025Common Stock · traded 12 February 2025 · filed 18 February 2025
- was granted 16,538 shares of Ani PharmaceuticalsSEC Form 418 February 2025Common Stock · traded 12 February 2025 · filed 18 February 2025
- had shares withheld for tax on 1,730 shares of Ani PharmaceuticalsSEC Form 418 February 2025Common Stock · traded 14 February 2025 · filed 18 February 2025
- ▼ sold on the open market 7,500 shares of Ani PharmaceuticalsSEC Form 418 December 2024Common Stock · traded 17 December 2024 · filed 18 December 2024
- ▼ sold on the open market 5,000 shares of Ani PharmaceuticalsSEC Form 46 June 2024Common Stock · traded 4 June 2024 · filed 6 June 2024
- had shares withheld for tax on 4,534 shares of Ani PharmaceuticalsSEC Form 411 April 2024Common Stock · traded 10 April 2024 · filed 11 April 2024
- had shares withheld for tax on 6,210 shares of Ani PharmaceuticalsSEC Form 425 March 2024Common Stock · traded 23 March 2024 · filed 25 March 2024
- had shares withheld for tax on 4,216 shares of Ani PharmaceuticalsSEC Form 411 March 2024Common Stock · traded 7 March 2024 · filed 11 March 2024
- ▼ sold on the open market 7,787 shares of Ani PharmaceuticalsSEC Form 411 March 2024Common Stock · traded 11 March 2024 · filed 11 March 2024
- had shares withheld for tax on 1,914 shares of Ani PharmaceuticalsSEC Form 41 March 2024Common Stock · traded 29 February 2024 · filed 1 March 2024
- was granted 21,474 shares of Ani PharmaceuticalsSEC Form 416 February 2024Common Stock · traded 14 February 2024 · filed 16 February 2024
- was granted 14,316 shares of Ani PharmaceuticalsSEC Form 416 February 2024Common Stock · traded 14 February 2024 · filed 16 February 2024
- ▼ sold on the open market 17,639 shares of Ani PharmaceuticalsSEC Form 416 August 2023Common Stock · traded 14 August 2023 · filed 16 August 2023
- had shares withheld for tax on 4,534 shares of Ani PharmaceuticalsSEC Form 412 April 2023Common Stock · traded 10 April 2023 · filed 12 April 2023
- was granted 24,316 shares of Ani PharmaceuticalsSEC Form 46 April 2023Common Stock · traded 28 February 2023 · filed 6 April 2023
- was granted 16,210 shares of Ani PharmaceuticalsSEC Form 46 April 2023Common Stock · traded 28 February 2023 · filed 6 April 2023
- had shares withheld for tax on 1,420 shares of Ani PharmaceuticalsSEC Form 430 March 2023Common Stock · traded 28 March 2023 · filed 30 March 2023
- had shares withheld for tax on 4,224 shares of Ani PharmaceuticalsSEC Form 427 March 2023Common Stock · traded 23 March 2023 · filed 27 March 2023
- had shares withheld for tax on 2,639 shares of Ani PharmaceuticalsSEC Form 49 March 2023Common Stock · traded 7 March 2023 · filed 9 March 2023
- had shares withheld for tax on 864 shares of Ani PharmaceuticalsSEC Form 49 March 2023Common Stock · traded 7 March 2023 · filed 9 March 2023
- was granted 11,291 shares of Ani PharmaceuticalsSEC Form 429 April 2022Common Stock · traded 27 April 2022 · filed 29 April 2022
- had shares withheld for tax on 4,534 shares of Ani PharmaceuticalsSEC Form 412 April 2022Common Stock · traded 10 April 2022 · filed 12 April 2022
- had shares withheld for tax on 912 shares of Ani PharmaceuticalsSEC Form 48 April 2022Common Stock · traded 6 April 2022 · filed 8 April 2022
- had shares withheld for tax on 1,420 shares of Ani PharmaceuticalsSEC Form 430 March 2022Common Stock · traded 28 March 2022 · filed 30 March 2022
- was granted 33,875 shares of Ani PharmaceuticalsSEC Form 428 March 2022Common Stock · traded 24 March 2022 · filed 28 March 2022
- had shares withheld for tax on 4,167 shares of Ani PharmaceuticalsSEC Form 425 March 2022Common Stock · traded 23 March 2022 · filed 25 March 2022
- had shares withheld for tax on 3,042 shares of Ani PharmaceuticalsSEC Form 413 April 2021Common Stock · traded 12 April 2021 · filed 13 April 2021
- had shares withheld for tax on 612 shares of Ani PharmaceuticalsSEC Form 47 April 2021Common Stock · traded 6 April 2021 · filed 7 April 2021
- had shares withheld for tax on 953 shares of Ani PharmaceuticalsSEC Form 431 March 2021Common Stock · traded 29 March 2021 · filed 31 March 2021
- had shares withheld for tax on 508 shares of Ani PharmaceuticalsSEC Form 431 March 2021Common Stock · traded 31 March 2021 · filed 31 March 2021
- was granted 54,470 shares of Ani PharmaceuticalsSEC Form 425 March 2021Common Stock · traded 23 March 2021 · filed 25 March 2021
- was granted 39,767 shares of Ani PharmaceuticalsSEC Form 414 April 2020Common Stock · traded 10 April 2020 · filed 14 April 2020
- had shares withheld for tax on 612 shares of Ani PharmaceuticalsSEC Form 48 April 2020Common Stock · traded 6 April 2020 · filed 8 April 2020
- had shares withheld for tax on 953 shares of Ani PharmaceuticalsSEC Form 431 March 2020Common Stock · traded 28 March 2020 · filed 31 March 2020
- had shares withheld for tax on 507 shares of Ani PharmaceuticalsSEC Form 431 March 2020Common Stock · traded 31 March 2020 · filed 31 March 2020
- had shares withheld for tax on 612 shares of Ani PharmaceuticalsSEC Form 49 April 2019Common Stock · traded 6 April 2019 · filed 9 April 2019
- had shares withheld for tax on 507 shares of Ani PharmaceuticalsSEC Form 42 April 2019Common Stock · traded 31 March 2019 · filed 2 April 2019
- was granted 15,064 shares of Ani Pharmaceuticals (a derivative holding)SEC Form 41 April 2019Stock Options · traded 28 March 2019 · filed 1 April 2019
- was granted 12,451 shares of Ani PharmaceuticalsSEC Form 41 April 2019Common Stock · traded 28 March 2019 · filed 1 April 2019
- was granted 9,600 shares of Ani Pharmaceuticals (a derivative holding)SEC Form 410 April 2018Stock Options · traded 6 April 2018 · filed 10 April 2018
- was granted 8,000 shares of Ani PharmaceuticalsSEC Form 410 April 2018Common Stock · traded 6 April 2018 · filed 10 April 2018
- had shares withheld for tax on 507 shares of Ani PharmaceuticalsSEC Form 43 April 2018Common Stock · traded 31 March 2018 · filed 3 April 2018
- was granted 6,625 shares of Ani PharmaceuticalsSEC Form 44 April 2017Common Stock · traded 31 March 2017 · filed 4 April 2017
- was granted 13,250 shares of Ani Pharmaceuticals (a derivative holding)SEC Form 44 April 2017Stock Options · traded 31 March 2017 · filed 4 April 2017
- was granted 50,000 shares of Ani Pharmaceuticals (a derivative holding)SEC Form 410 May 2016Option to Purchase · traded 6 May 2016 · filed 10 May 2016
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.